Data Analytics Platform for Disparate Internal Sources

Tag.bio accelerates the drug development process by reducing the time and effort required to manage and analyze data. Data is harmonized to create a catalogue of self-service data products spanning discovery, clinical trials, and real-world evidence. The Tag.bio platform enables pharmaceutical companies to analyze harmonized data in seconds, accelerating data-driven decisions, reducing time to publication, and minimizing the cost of curiosity-driven discovery. With deployments at several major pharmaceutical companies, and leveraged across the full range of drug development, their product makes data accessible and usable to both scientists and data scientists.

San Francisco, CA
Tom Covington, CEO
Mark Mooney, VP Customer
Return to Alumni Page

More Alumni Startups